AI assistant
Glenmark Pharmaceuticals ltd — Call Transcript 2022
Feb 13, 2022
62608_rns_2022-02-13_30912dbe-7597-48f6-9c71-cd249d6a6fb5.pdf
Call Transcript
Open in viewerOpens in your device viewer
==> picture [119 x 62] intentionally omitted <==
February 13, 2022
To, To, Dy. General Manager The Manager – Listing, Department of Corporate Services, National Stock Exchange of India Ltd., BSE Ltd., Plot No. C/1, G Block, P. J. Towers, Dalal Street, Bandra Kurla Complex, Fort, Mumbai – 400 001 Bandra (E), Mumbai – 400 051
Ref: Scrip Code: 532296
Ref: Scrip Name: GLENMARK
Dear Sirs,
Enclosed please find herewith the details of Earnings Call slated for Monday, February 14, 2022 at 8:30 a.m. – 9:30 a.m. (IST) , for your information and record. Please note that the recording of the call will be available on our website within 24 hours of the call.
Thanking you.
Yours faithfully,
For Glenmark Pharmaceuticals Ltd.
==> picture [81 x 49] intentionally omitted <==
Harish Kuber Company Secretary & Compliance Officer
Tel: 4018 9999 / 4018 9879 Fax: 4018 9986 (Legal & Secretarial Dept.)
Encl: As above
Glenmark Pharmaceuticals Ltd. Glenmark House, B D Sawant Marg, Andheri (E), Mumbai 400 099 T: 91 22 4018 9999 F: 91 22 4018 9988 CIN: L24299MH1977PLC019982 W: www.glenmarkpharma.com Registered office: B/2, Mahalaxmi Chambers, 22 Bhulabhai Desai Road, Mumbai 400 026 E: [email protected]
==> picture [139 x 99] intentionally omitted <==
I N V I T A T I O N
Glenmark Q3 FY 2021 – 22 Results Earnings Call
Date: Monday, February 14, 2022 Time: 8:30 am – 9:30 am [IST]
Dial – in Numbers: Universal Access Number: +91 22 6280 1298 +91 22 7115 8199
USA: 1 866 746 2133 UK: 0 808 101 1573 Singapore: 800 101 2045 Hong Kong: 800 964 448
To pre-register online, please click here
For any clarification, please contact:
Pragya Verma
E-mail: [email protected]
Phone: +91 22 4018 9783